StockData
Agentix Corp. logo

Agentix Corp. (AGTX) stock

AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 0/30
$0.02+0.00 (0.00%)

Close on Oct 16, 2026Market cap $801.34KP/E –Yield –

Agentix price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Agentix's price to sales ratio was 151.9× on Dec 29, 2017, against 8.8× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Dec 29, 2017151.9×+144.0
2016Dec 30, 20167.9×−0.9
2015Dec 31, 20158.8×–

More Agentix figures

See a number that looks wrong?